Anticoagulation in Intracerebral Hemorrhage (ICH) Survivors for Stroke Prevention and Recovery (ASPIRE): A StrokeNet Study
This study is a randomized, double-blinded, phase III clinical trial designed to test the efficacy and safety of anticoagulation, compared with aspirin, in patients with a recent ICH and high-risk non-valvular atrial fibrillation/flutter (AF).
Project Type: Research
Year started: 2021
Diagnosis: Stroke